U.S. Spent $290mil on Radiation Sickness Drugs

On Tuesday, the United States Department of Health and Human Services (HHS) purchased $290million of drugs for radiological and nuclear emergencies.

Officials said the deal was ‘part of ongoing work’ and ‘has not been accelerated’ by Vladimir Putin’s escalating threats of nuclear warfare.

The purchase of romiplostim (branded Nplate) is being presented as standard and routine.

Administration for Strategic Preparedness & Response announced:

“As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).”

It’s unclear how many doses were ordered, though the typical price for Nplate is between $1,000 and $2,500 per dose. 

Join The Discussion

Related Posts